TREMFYA sol inj 100 mg/ml ser pré 1 ml
7680665830018
CH-66583
L04AC16
07.15.0.
Reimbursement limitations:
TREMFYA3
Arthrite psoriasique
Traitement des patients adultes souffrant d'arthrite psoriasique active, seul ou en combinaison avec …
1 / 3
google
Details
- Product number
- 6658301
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- guselkumabum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Tremfya 100 mg/1 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2299.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2018
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 66583
- Drug name
- Tremfya, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AC16
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TREMFYA sol inj 100 mg/ml ser pré 1 ml
- Description (DE)
- TREMFYA Inj Lös 100 mg/ml Fertspr 1 ml
- Market launch
- 13/06/2018
- Narcotic (BTM)
- No